Vyripharm Enterprises, Inc.

Pharmaceutical company · Houston, Texas, United States

Vyripharm Enterprises, Inc. is a pharmaceutical company headquartered in Houston, Texas, United States. Its earliest recorded incorporation is in 2014. It has reported private securities offerings to the US SEC, most recently $300 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Vyripharm Enterprises at a glance

Typepharmaceutical company

HeadquartersHouston, Texas, United States

Earliest incorporation on record2014

SEC CIK1681739, 1887609

What does Vyripharm Enterprises do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $300 million sold (2021).

Frequently asked questions about Vyripharm Enterprises

Where is Vyripharm Enterprises headquartered?

Vyripharm Enterprises, Inc. is headquartered in Houston, Texas, United States.

What does Vyripharm Enterprises do?

Vyripharm Enterprises, Inc. is a pharmaceutical company.

When was Vyripharm Enterprises founded?

The earliest incorporation on record for Vyripharm Enterprises, Inc. is in 2014, according to public company registers.

Similar companies

Marker Therapeutics, Inc.Houston, Texas, United States
7 Hills Pharma Inc.Houston, Texas, United States
Decoy Therapeutics Inc.Houston, Texas, United States
CNS Pharmaceuticals, Inc.Houston, Texas, United States
Coya Therapeutics, Inc.Houston, Texas, United States
Aravive, Inc.Houston, Texas, United States
Beta Cat Pharmaceuticals, Inc.Houston, Texas, United States
Moleculin Biotech, Inc.Houston, Texas, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences